Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment

J Nephrol. 2017 Apr;30(2):155-157. doi: 10.1007/s40620-017-0378-x. Epub 2017 Feb 17.

Authors

Claudio Ponticelli¹, David Cucchiari²

Affiliations

¹ Humanitas Clinical and Research Center, via Manzoni 56, 20089, Rozzano, MI, Italy. ponticelli.claudio@gmail.com.
² Humanitas Clinical and Research Center, via Manzoni 56, 20089, Rozzano, MI, Italy.

PMID: 28211033
DOI: 10.1007/s40620-017-0378-x

No abstract available

Publication types

Editorial

MeSH terms

Angiotensin II Type 1 Receptor Blockers / adverse effects
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / adverse effects
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Antihypertensive Agents / adverse effects
Antihypertensive Agents / therapeutic use*
Arterial Pressure / drug effects*
Clinical Decision-Making
Humans
Hypertension / diagnosis
Hypertension / drug therapy*
Hypertension / etiology
Hypertension / physiopathology
Kidney Transplantation / adverse effects*
Renin-Angiotensin System / drug effects*
Risk Assessment
Risk Factors
Treatment Outcome

Substances

Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents